Targeting Peripheral & Cardiac Metabolism for Therapeutic Benefits in Heart Failure
Time: 8:45 am
day: Day Two
Details:
- Evaluate how the metabolic HFpEF pheno-group is associated with obesity and diabetes and is increasing in prevalence
- Discover how metabolic therapies such as exercise have shown benefit in HFpEF across multiple trials
- Learn how targeting dysregulated branched-chain amino acid metabolism has demonstrated efficacy in preclinical HFpEF models
